Price Alert

Kamada Ltd. (KMDA)

NASDAQ: KMDA · Real-Time Price · USD

7.25

-0.05 (-0.68%)

At close: Aug 15, 2025, 12:51 PM

-0.68% (1D)

Bid	7.25
Market Cap	416.91M
Revenue (ttm)	166.64M
Net Income (ttm)	16.06M
EPS (ttm)	0.32
PE Ratio (ttm)	22.66
Forward PE	18.21
Analyst	Buy

Ask	7.33
Volume	11,806
Avg. Volume (20D)	66,040
Open	7.32
Previous Close	7.30
Day's Range	7.25 - 7.33
52-Week Range	5.17 - 9.15
Beta	0.71

About KMDA

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol KMDA

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for KMDA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Earnings Surprise

Kamada has released their quartely earnings on Aug 13, 2025:

Revenue of $38.44M misses estimates by $73.48M, with -1.81% YoY decline.

EPS of 0.13 exceeds estimates by 0.04, with 62.50% YoY growth.

Next Earnings Release

Kamada Ltd. is scheduled to release its earnings on Nov 12, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

5 months ago

+7.41%

Kamada shares are trading higher after the company... Unlock content with Pro Subscription

6 months ago

+6.36%

Kamada shares are trading higher after the company announced a contract award for the supply of KAMRAB and VARIZIG in Latin America for 2025-2027.

News

1 day ago · zacks.com

What Makes Kamada (KMDA) a New Buy Stock

Kamada (KMDA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

18 hours ago · zacks.com

KMDA vs. ILMN: Which Stock Is the Better Value Option?

Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Kamada (KMDA) and Illumina (ILMN). But which of these two stocks offers value investors a better bang for thei...

20 hours ago · zacks.com

Are Investors Undervaluing Kamada (KMDA) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest...

2 days ago · seekingalpha.com

Kamada Ltd. (KMDA) Q2 2025 Earnings Call Transcript

Kamada Ltd. (NASDAQ:KMDA ) Q2 2025 Earnings Conference Call August 13, 2025 8:30 AM ET Company Participants Amir London - Chief Executive Officer Chaime Orlev - Chief Financial Officer Conference Call...

1 day ago · zacks.com

Kamada (KMDA) Reports Q2 Earnings: What Key Metrics Have to Say

The headline numbers for Kamada (KMDA) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates ...

1 day ago · zacks.com

Kamada (KMDA) Q2 Earnings Top Estimates

Kamada (KMDA) came out with quarterly earnings of $0.13 per share, beating the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.08 per share a year ago.

1 month ago · zacks.com

KMDA or ACAD: Which Is the Better Value Stock Right Now?

Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Kamada (KMDA) and Acadia Pharmaceuticals (ACAD). But which of these two stocks offers value investors a better...

1 month ago · zacks.com

Is Kamada (KMDA) Stock Undervalued Right Now?

1 month ago · zacks.com

KMDA vs. ACAD: Which Stock Is the Better Value Option?

Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Kamada (KMDA) or Acadia Pharmaceuticals (ACAD). But which of these two stocks is more attract...

2 months ago · zacks.com

Wall Street Analysts Think Kamada (KMDA) Could Surge 106.86%: Read This Before Placing a Bet

The consensus price target hints at a 106.9% upside potential for Kamada (KMDA). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate ...

Load More News